-NDTV Employment under the Mahatma Gandhi National Rural Employment Guarantee Act or MNREGA has declined, while Rs. 128 crore have been misused and work worth a staggering Rs. 4000 crore is incomplete, the government's auditor has alleged in its review of the rural job scheme that the Congress-led UPA government counts as one of its most significant achievements in the last nine years of rule at the Centre. In its report...

KEY TRENDS   • According to National Sample Survey report no. 583: Persons with Disabilities in India, the percentage of persons with disability who received aid/help from Government was 21.8 percent, 1.8 percent received aid/help from organisation other than Government and another 76.4 percent did not receive aid/ help *8   • As per National Family Health Survey-4 (NFHS-4), the Under-five Mortality Rate (U5MR) was 57.2 per 1,000 live births (for the non-STs it was 38.5)...

-The Hindustan Times Far from the neatly trimmed lawns of India Gate that so often reverberate with cries for justice, far also from the corridors of power where ministries recently squabbled over the right age for consensual sex, lie 197 districts - yes 197, read the figure again - where children are regularly abused. In these districts -- all ridden by conflict -- words like illegal detention, arbitrary arrests, sexual violence, torture...

-Tehelka With 65 percent of the population below the age of 35, India boasts of an unparalleled generational dividend, but are we turning this potential into a disaster? Avalok Langer spots a ticking time bomb Nutrition & Health* 40% of children in India are malnourished 43% of children in the age group of 12-23 months receive full immunisation 48%+ of children are underweight 50%+ of all deaths under age 5 are related to malnutrition 45% of children...

-Reuters Global drugmakers, battered by recent intellectual property decisions in the country, are girding for a landmark court ruling on Monday with broad consequences for their ability to sell lucrative patented medicines in the country. Supreme Court is due to decide on April 1 whether or not Swiss giant Novartis AG's cancer treatment Glivec deserves a patent in the country. "Big Pharma is nervous because nothing has gone in their favour in the...